Andrew Septimus

Andrew "Mo" Septimus is the Chief Financial Officer at Lykos Therapeutics, involved in drug development and commercialization. Before his current role, he was the CFO at MAPS and Izun Pharmaceuticals, and led the sale of ebbu to Canopy Growth Corp. With a background in finance and agribusiness economics, he has held various leadership positions in companies like Algae Systems, Kuzari Group, and the National Archives.